21
Apr
2024
Mounjaro: miracle or curse?
Posted On April 21, 2024
By [email protected]
And has No Comment
Mounjaro is a relatively new medication, approved in 2022 for the treatment of type 2 diabetes. It belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, which work by increasing insulin secretion and decreasing glucagon secretion. Mounjaro is an injectable prescription medicine that adults with […]
Read More
